JAMA Oncology

JAMA Oncology JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed publications.

Individuals diagnosed with cancer in 2020 and 2021 had lower 1-year survival than before the pandemic, with greatest imp...
02/10/2026

Individuals diagnosed with cancer in 2020 and 2021 had lower 1-year survival than before the pandemic, with greatest impact seen in older adults and non-Hispanic minority groups.

https://bit.ly/4qgWKPW

Individuals diagnosed with cancer in 2020 and 2021 had lower 1-year survival than before the pandemic, with greatest imp...
02/08/2026

Individuals diagnosed with cancer in 2020 and 2021 had lower 1-year survival than before the pandemic, with greatest impact seen in older adults and non-Hispanic minority groups.

https://bit.ly/4ajkNId

Individuals diagnosed with cancer in 2020 and 2021 had lower 1-year survival than before the pandemic, with greatest imp...
02/08/2026

Individuals diagnosed with cancer in 2020 and 2021 had lower 1-year survival than before the pandemic, with greatest impact seen in older adults and non-Hispanic minority groups.

https://bit.ly/4qz1UXS

Individuals diagnosed with cancer in 2020 and 2021 had lower 1-year survival than before the pandemic, with greatest imp...
02/06/2026

Individuals diagnosed with cancer in 2020 and 2021 had lower 1-year survival than before the pandemic, with greatest impact seen in older adults and non-Hispanic minority groups.

https://bit.ly/4qgWHUg

A secondary analysis of the GHSG HD21 randomized trial evaluated health-related quality of life among patients with adva...
02/06/2026

A secondary analysis of the GHSG HD21 randomized trial evaluated health-related quality of life among patients with advanced-stage classic receiving BrECADD vs escalated BEACOPP regimens.

BrECADD was associated with reduced chemotherapy-related symptoms, including lower rates of peripheral neuropathy, cognitive fatigue, and dyspnea, and improved physical and role functioning after 4 cycles in PET2-negative patients.

Enhanced cognitive, emotional, and social functioning persisted through the second year of follow-up, supporting BrECADD’s favorable tolerability and recovery profile.

https://bit.ly/3OqNMlN

A population-based cohort study analyzed more than 1 million US patients diagnosed with cancer during 2020 and 2021 to a...
02/05/2026

A population-based cohort study analyzed more than 1 million US patients diagnosed with cancer during 2020 and 2021 to assess short-term survival outcomes during the COVID-19 pandemic.

Compared with 2015–2019 trends, patients diagnosed in the first 2 pandemic years experienced significant reductions in 1-year cause-specific survival, both for early-stage and late-stage cancers, resulting in approximately 17,390 additional deaths (13.1%) than expected.

Survival reductions occurred across most cancer sites and population subgroups, with notable impact on individuals aged ≥65 years and those of non-Hispanic minority race and ethnicity.

https://bit.ly/4atpwbn

Low-dose aspirin in older adults was not associated with lower incidence over 8.6 years, and cancer mortality risk did...
02/03/2026

Low-dose aspirin in older adults was not associated with lower incidence over 8.6 years, and cancer mortality risk did not persist beyond the exposure period.

https://ja.ma/4aq6AtY

📢 Special Communication from JAMA: Opportunistic salpingectomy during pelvic or selected abdominal is associated with ...
02/03/2026

📢 Special Communication from JAMA: Opportunistic salpingectomy during pelvic or selected abdominal is associated with lower risk of tubo-ovarian and minimal surgical risk.

Existing evidence indicates that this preventive procedure does not adversely affect short-term function, adds minimal operative time, and does not appear to increase perioperative risks, although long-term effects on ovarian health remain uncertain.

https://ja.ma/45IWZMp

This JAMA Oncology Patient Page describes the 3 main types of urinary diversions and care required after surgery to ensu...
02/03/2026

This JAMA Oncology Patient Page describes the 3 main types of urinary diversions and care required after surgery to ensure an active and fulfilling life.

https://ja.ma/45IZSgd

The addition of camrelizumab to chemotherapy produced statistically significant and clinically meaningful 5-year OS bene...
02/02/2026

The addition of camrelizumab to chemotherapy produced statistically significant and clinically meaningful 5-year OS benefits compared with chemotherapy alone in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma.

https://ja.ma/3Z8lXkB

Patients with muscle-invasive bladder cancer may undergo a surgery called radical cystectomy (removal of the bladder). O...
02/01/2026

Patients with muscle-invasive bladder cancer may undergo a surgery called radical cystectomy (removal of the bladder). Once the bladder is removed, the body needs a new way to pass urine, which is called a urinary diversion.

This JAMA Oncology Patient Page describes the 3 main types of urinary diversions and care required after surgery to ensure an active and fulfilling life.

https://ja.ma/4tbj7c4

Address

330 N Wabash Avenue
Chicago, IL
60611

Telephone

+13126707827

Website

Alerts

Be the first to know and let us send you an email when JAMA Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category